168 related articles for article (PubMed ID: 34425650)
21. "Chronic" metastatic pancreatic acinar cell carcinoma.
Cananzi FC; Jayanth A; Lorenzi B; Belgaumkar A; Mochlinski K; Sharma A; Mudan S; Cunningham D
Pancreatology; 2013; 13(5):549-52. PubMed ID: 24075523
[TBL] [Abstract][Full Text] [Related]
22. Six monoclonal antibodies to human pancreatic cancer antigens.
Kajiji SM; Davceva B; Quaranta V
Cancer Res; 1987 Mar; 47(5):1367-76. PubMed ID: 3815343
[TBL] [Abstract][Full Text] [Related]
23. Ductal and acinar differentiation in pancreatic endocrine tumors.
Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M; Yamaguchi T
Dig Dis Sci; 2002 Oct; 47(10):2254-61. PubMed ID: 12395898
[TBL] [Abstract][Full Text] [Related]
24. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
25. FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case report.
Schempf U; Sipos B; König C; Malek NP; Bitzer M; Plentz RR
Z Gastroenterol; 2014 Feb; 52(2):200-3. PubMed ID: 24526405
[TBL] [Abstract][Full Text] [Related]
26. Clinical outcomes of patients with resectable pancreatic acinar cell carcinoma.
Seo S; Yoo C; Kim KP; Ryoo BY; Chang HM; Hong SM; Lee JH; Song KB; Hwang DW; Kim KH; Hwang S; Kim SC
J Dig Dis; 2017 Aug; 18(8):480-486. PubMed ID: 28671770
[TBL] [Abstract][Full Text] [Related]
27. [A case of liver metastasis of mixed acinar-endocrine carcinoma treated with various loco-regional cancer therapies].
Nishii T; Amano R; Nakao S; Doi Y; Yamada N; Ohira M; Hirakawa K
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2126-8. PubMed ID: 19106545
[TBL] [Abstract][Full Text] [Related]
28. Neurogenin 3-directed cre deletion of Tsc1 gene causes pancreatic acinar carcinoma.
Ding L; Han L; Li Y; Zhao J; He P; Zhang W
Neoplasia; 2014 Nov; 16(11):909-17. PubMed ID: 25425965
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibodies for the measurement of class-specific antibody responses in the green turtle, Chelonia mydas.
Herbst LH; Klein PA
Vet Immunol Immunopathol; 1995 Jun; 46(3-4):317-35. PubMed ID: 7502491
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal carcinoma-associated antigen defined by a murine monoclonal antibody.
Chin JK; Rong GH; Scharff JE; Sindelar WF
J Natl Cancer Inst; 1986 Sep; 77(3):599-604. PubMed ID: 3528605
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic characterisitics of pancreatic acinar cell carcinomas].
Ding XH; Wang ZB; Qiu XM
Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):274-278. PubMed ID: 29690667
[No Abstract] [Full Text] [Related]
32. Human pancreatic cancer fusion 2 (HPC2) 1-B3: a novel monoclonal antibody to screen for pancreatic ductal dysplasia.
Morgan TK; Hardiman K; Corless CL; White SL; Bonnah R; Van de Vrugt H; Sheppard BC; Grompe M; Cosar EF; Streeter PR
Cancer Cytopathol; 2013 Jan; 121(1):37-46. PubMed ID: 22811080
[TBL] [Abstract][Full Text] [Related]
33. New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.
Velders MP; Litvinov SV; Warnaar SO; Gorter A; Fleuren GJ; Zurawski VR; Coney LR
Cancer Res; 1994 Apr; 54(7):1753-9. PubMed ID: 8137290
[TBL] [Abstract][Full Text] [Related]
34. [Monoclonal antibody to human pancreatic carcinoma cells].
Koyama S; Fukao K; Osuga T
Gan No Rinsho; 1987 Jan; 33(1):42-7. PubMed ID: 3820599
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody 16D10 to the COOH-terminal domain of the feto-acinar pancreatic protein targets pancreatic neoplastic tissues.
Benkoël L; Bernard JP; Payan-Defais MJ; Crescence L; Franceschi C; Delmas M; Ouaissi M; Sastre B; Sahel J; Benoliel AM; Bongrand P; Silvy F; Gauthier L; Romagné F; Lombardo D; Mas E
Mol Cancer Ther; 2009 Feb; 8(2):282-91. PubMed ID: 19190122
[TBL] [Abstract][Full Text] [Related]
36. A monoclonal antibody, 4H12, recognizes a surface antigen found on granulated metrial gland cells in the murine decidua.
Linnemeyer PA; Hamilton MS
J Reprod Immunol; 1990 Jun; 17(3):279-94. PubMed ID: 2213725
[TBL] [Abstract][Full Text] [Related]
37. Patients With Acinar Cell Carcinoma of the Pancreas After 2005: A Large Population Study.
Zong Y; Qi C; Peng Z; Shen L; Zhou J
Pancreas; 2020 Jul; 49(6):781-787. PubMed ID: 32541633
[TBL] [Abstract][Full Text] [Related]
38. [Preparation and characterization of monoclonal anti-anti-idiotypic antibody (3D12) of epithelial ovarian carcinoma].
Zhang C; Cui H; Li Xp; Ye X; Fu Ty; Feng J; Chang Xh; Wei LH
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):170-3. PubMed ID: 18458693
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic Ductal Adenocarcinoma in Remnant Pancreas after Pancreaticoduodenectomy for Acinar Cell Carcinoma: A Case Report.
Nishimura S; Utsumi M; Aoki H; Une Y; Kashima H; Kimura Y; Taniguchi F; Arata T; Katsuda K; Tanakaya K; Sato Y
J Nippon Med Sch; 2019 Dec; 86(5):279-283. PubMed ID: 31061255
[TBL] [Abstract][Full Text] [Related]
40. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D
Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
